$IBRX ImmunityBio Investors

[text] ImmunityBio $IBRX 2026 Key Milestone Roadmap February - Announcement of Saudi Arabia Investment Results: Official confirmation of the massive capital influx from Saudi sources. March - Projected Earnings Surprise: Expected explosive revenue growth following the Anktiva

[image] Here is the $IBRX analysis and data I’ve compiled. ​I’m sharing this once again, as I believe it will be helpful to reference for your investment decisions. @DrPatrick @ImmunityBio

[image] #ImmunityBio is set to lead an infinite cancer treatment market. :) Our community is looking for fellow investors who believe in $IBRX vision and wish to join us on this journey. We look forward to seeing you there!!

[image] Why isn’t $IBRX spiking toward $100? With over 40% of the float short and massive upside potential, this stock should be trading like Moderna did during the pandemic. Cancer is the real pandemic—arguably bigger—a global catastrophic disease. The market is asleep.

[video] Cancer is a shape-shifting disease, but we are now one step ahead. A 'World Bank of NK Cells' created with IL-15 and healthy donor cells... This technology, allowing immediate treatment for anyone without matching, is set to become a reality by 2026!! $ibrx @DrPatrick

[video] Once #ImmunityBio automated NK cell factory receives production approval, treatment costs could drop by more than 80% compared to existing therapies. Beyond being a cancer treatment, Anktiva has the potential to fundamentally transform the human immune system $IBRX @DrPatrick

[image] $ibrx big deal!!